Bluebird receives positive opinion from CHMP for lentiglobin, Feuerstein says
STAT’s Adam tweeted, “$BLUE the EMA’s CHMP issued a positive opinion (approval recommendation) of lentiglobin gene therapy for transfusion-dependent beta thalassemia. Brand name: Zyntelgo.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.